Persistent SARS-CoV-2 PCR positivity despite anti-viral treatment in immunodeficient patients
M Chan, MMN Linn, T O'Hagan… - Journal of Clinical …, 2023 - Springer
Purpose COVID-19 infection in immunodeficient individuals can result in chronically poor
health, persistent or relapsing SARS-CoV-2 PCR positivity, and long-term infectious …
health, persistent or relapsing SARS-CoV-2 PCR positivity, and long-term infectious …
[HTML][HTML] Viral dynamics of SARS-CoV-2 in immunocompromised patients
AN Utzon, IS Johansen, LL Bang, RM Pedersen… - Clinical Microbiology …, 2023 - Elsevier
Objectives Immunocompromised patients infected with SARS-CoV-2 have been shown to
shed replicable virus for a prolonged period of time, and the duration of isolation can …
shed replicable virus for a prolonged period of time, and the duration of isolation can …
Retrospective Case-Control Study of REGEN-COV (casirivimab and imdevimab) Therapy for Patients with COVID-19 and Cancer Using the United States MarketScan …
K Takemoto - Oncology, 2024 - karger.com
Introduction: Patients with cancer may be at a higher risk of experiencing severe
complications from coronavirus disease 2019 (COVID-19) than are patients without cancer …
complications from coronavirus disease 2019 (COVID-19) than are patients without cancer …
[HTML][HTML] Persistent SARS-CoV-2 PCR positivity despite treatment in immunodeficient patients
M Chan, MMN Linn, T O'Hagan, JA Guerra-Assunção… - 2022 - europepmc.org
Purpose: COVID-19 infection in immunodeficient individuals can result in chronically poor
health, persistent or relapsing SARS-CoV-2 PCR positivity, and long-term infectious …
health, persistent or relapsing SARS-CoV-2 PCR positivity, and long-term infectious …